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Summary 
The aim of this study was to investigate the in vitro effects of interleukin-lfl (IL-lfl) on cultured human articular 
chondrocytes from patients with osteoarthritis, bythe evaluation of glucose uptake. We also investigated the inhibitory 
effect of cortisol on IL-lfl-mediated glucose uptake. Experiments were performed by using 2-deoxy-D- 
[1-3H]glucose (2-DOG) and confluent monolayer cells at first passage. Confluent cells were also treated for 24 h with 
different concentrations of cortisol (10 -5, 10 -6 and 10 -7 mol/1). IL-lfl (100 pg/ml) was added 6 h before glucose uptake 
studies. 
Glucose uptake stimulation was observed 3 h after the addition of 100 pg/ml IL-lfl (+70%) and increased up to 24 h 
(+145%). The sensitivity and responsiveness of chondrocytes to IL-lfl, studied after a 6 h association time, appeared 
to be dose-dependent from 0.1 pg/ml IL-lfl (+50%) to 100 pg/ml (+130%) over basal values. The effect of the cytokine 
was protein synthesis-dependent, as demonstrated byusing cycloheximide. Cortisol inhibited the action of IL-lfl on 
glucose uptake because it reduced stimulating effects by 28% at concentrations as weak as 10 -6 mol/1. Results appeared 
similar when IL-lfl and cortisol were added simultaneously 6 h before 2-DOG uptake. The rapid effect of cortisol was 
protein-synthesis dependent, as indicated by inhibition by cycloheximide. These results suggest that IL-lfl stimulates 
chondrocyte metabolic activity. The inhibition of IL-lfl-mediated glucose uptake is suggested for studying the anti-IL-1 
effect of other anti-rheumatic drugs. 
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Introduction 
INFLAMMATION and joint destruction in osteoar- 
thritis (OA) a re in  part regulated by local 
cytokines. Interleukin-lf l  (IL-lfl) was demonstrated 
to induce a wide range of effects on art icular 
chondrocytes. IL-lfl stimulates secretion of col: 
lagenase [1], stromelysin [2], prostaglandin E2 [3] 
and cytokines as interleukin-6 [4], interleukin-8 [5], 
or hemopoietic o!0ny-st!mulating factor [6]. All 
these syntheses require energy supply, Which could 
be partly realized by glucose uptake, The aim of 
this paper was to study the effect of IL-!fl on 
glucose uptake by human cultured art icular 
chondrocytes by using 2-de0xy-D:glucose, a
non-metabolizable analog of D-glucose. 
In view of the potential interest of cytokine 
reduction in the treatment of joint conditions [7], 
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we investigated the possibility of using the IL- 
lfl-mediated glucose uptake by human cultured 
chondrocytes to evaluate drugs with potential  
anti-IL-lfl activity. We, therefore, studied the effect 
of pharmacological doses of cortisol, because of 
the interest of this drug to osteoarthrit is [8, 9]. 
Materials and methods 
SOURCES 
Ham's F12 medium, and phosphate-buffered 
saline (PBS) were from GIBCO (Paisley, Scotland), 
fetal calf serum (FCS) was from BioWHITTAKER 
(Fontenay sous-bois, France). Clostridia collagen- 
ase (type Ia), porcine trypsin, cycloheximide 
(CHX), cortisol, indomethacin and 2-deoxy-D- 
glucose were f rom Sigma (St. Louis, MO, U.S.A.). 
Human recombinant IL-lfl (hr-IL-lfl) was from 
Genzyme (Boston, MA, U.S.A.). 2-deoxy-D-[1-3H]- 
glucose (2-DOG) (specific activity 15-25 Ci/10 -3 mol) 
was from Amersham International (Bucks, U.K.). 
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ARTICULAR CHONDROCYTES CULTURES 
Human chondrocytes were isolated from surgical 
samples of art icular cartilage obtained during 
joint surgery from patients with osteoarthrit ic 
hips. Small fragments of cartilage were enzymati- 
cally digested using trypsin and collagenase. Cells 
were suspended in Ham's F12 containing 10% FCS, 
netilmicin, ceftazidin, vancomycin and fungizone 
and were plated at 1.5 × 105 cells in 75 cm 2 culture 
flasks. Cells were cultured until confluence in 
Ham's F12 with 10% FCS, at 37°C, in an 
atmosphere containing 5% CO2. The medium was 
changed every 3 days. When confluence was 
attained, a passage was carried out, using trypsin. 
Cells (7 x 10 -4) were suspended in 1 ml of Ham's F12 
with 10% FCS and placed in 4 cm ~ 12-well plates at 
37°C (5% CO2). All experiments were performed on 
confluent cultures at first passage. 
TREATMENT WITH HUMAN RECOMBINANT IL-I~ 
The growth medium of the chondrocyte cul- 
tures was replaced by fresh medium containing 
2% FCS and either various concentrations of IL-lfl 
(0-1 ng/ml) for 6 h or 100 pg/ml IL-lfl for 6 h and 
various other times (1, 3, 6 and 24 h). Uptake assays 
were then performed. 
PHARMACOLOGICAL EFFECT ASSESSMENT 
The growth medium of the cultures was replaced 
by fresh medium containing 2% FCS. Cells were 
incubated in the presence of cortisol (10 -5, 10 -~ and 
10 -7 mol/1) for either 6 or 24 h. When used, IL-lfl 
100pg/ml was added for the last 6h  without 
changing the medium. At the end of these 6 or 
24h-incubation times, uptake assays were then 
performed. In some experiments, cells were incu- 
bated with 10 -4 mol/1 CHX during these 6 or 24 h 
incubation periods. 
2-DOG UPTAKE 
2-DOG uptake assays were performed as pre- 
viously described [10]. Briefly, cultures were 
washed three times with 2 ml PBS pH 7.4, and 
incubated for 5 min with 1 ml PBS containing 
0.5mmol/1 2-DOG (2ttCi/ml). The incubation 
medium was then removed and the dishes rinsed 
three times with ice-cold PBS. The cell monolayers 
were dissolved in 1 mol/1 NaOH and radioactivity 
was counted in a liquid scintil lation counter. Total 
cell protein was assayed according to Lowry et al. 
[11] with bovine serum albumin as standard. 
Results are expressed as 103 cpm/mg protein per 
5 min. 
STATISTICAL ANALYSIS 
Values are given as mean _+ standard error of 
mean of triplicate measurements. Comparisons 
were made using the Mann-Whitney U-test. 
Differences with P values of less than 0.05 were 
considered significant. 
Results  
Glucose uptake stimulation' occurred 3 h after 
the addition of 100pg/ml IL- lf l  (+70%) and 
increased up to 24 h (+145%; Fig. 1). The sensitivity 
and responsiveness of chondrocytes to IL-lfl, 
studied after a 6 h association time, appeared to be 
dose-dependent (Fig. 2). 2-DOG uptake was signi- 
ficantly increased over basal values at concen- 
trations from 0.1 pg/ml (10 950 cpm/mg proteins per 
5 min vs 7300) to I ng/ml (18 600 cpm/mg proteins 
per 5min). The action of IL-lfl was protein 
synthesis dependent, because CHX inhibited about 
86% of the effect of the cytokine. 
As indicated in Fig. 3, cortisol 10-5mol/1 
inhibited IL-lfl-mediated glucose uptake, reducing 
stimulating, effects by 28% after a 24-h association 
time. A dose-effect was observed with cortisol, with 
an IL-lfl stimulating effect reduced by 39% for a 
10 -5 mol/1 concentration, The anti-IL-lfl effect was 
similar when cytokine and cortisol were simul- 
taneously added for a 6-h incubation time. The 
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FIG. 1. Time course of IL-lfl stimulation of 2-DOG uptake 
by human cultured articular chondrocytes from patients 
with OA (N= 3). Values represent the stimulating effect 
of IL-lfl on glucose uptake (mean _+ S.E.M.) vs control 
cultures incubated for comparable time periods in fresh 
medium + FCS alone. *P < 0.05 compared with control 
cultures. 
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Fro. 2. Effects of increasing concentrations of IL-lfl on 
2-DOG uptake by human cultured articular ehondroeytes 
from patients with OA (N=3). Values represent he 
stimulating effect of IL-lfl on glucose uptake (mean_+ 
S.E.M.). *P < 0.05 compared with control cultures. 
act ion of cort isol  was prote in synthesis-dependent,  
s ince CHX (10-4mol/1, 6h)  inhibited about 91% 
of the effect of the drug. An effect of cort isol  
on unst imulated chondrocyte cultures was also 
observed (Fig. 4). Cort isol  10-5mol/1 reduced 
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FIG. 3. Effect of cortisol, after a 6- or 24-h incubation, on 
IL-lfl-mediated 2-deoxy-D-glucose uptake by human 
cultured articular chondrocytes from patients with OA 
(N= 3). IL-lfl was added either simultaneously with the 
drug (set 6-h incubation) or in the last 6 h of the 24-h 
incubation time with the drug (set 24-h incubation). 
Whatever the situation, values (mean + S.E.M.) represent 
the effect on IL-lfl-mediated glucose uptake (set at 
100%). *P < 0.05 vs 'IL-lfl alone' experimental values 
(15 800 + 2520cpm/mg proteins per 5rain) ([~), IL-lfl 
alone; ( I ) ,  10 -7 mol/1; (~3), 10.6 mol/1; (~3), 10 -~ mol/1. 
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FIG. 4. Effect of cortisol, after a 6 or 24 h incubation, on 
2-deoxy-D-glucose uptake by human cultured articular 
chondrocytes from patients with OA (N= 3). Results are 
expressed in cpm/mg proteins per 5 min _+ S.E.M. 
*P < 0.05 compared to basal values. ([:]), untreated cells; 
( I ) ,  10 -7 mol/1; ([]), 10 .6 mol/1; ([]), 10 -5 mol/1. 
basal glucose uptake (about -40%) whatever  the 
incubat ion  time. 
Discuss ion  
In recent  years, IL-lfl has been demonstrated 
to induce a wide range of effects on ar t i cu lar  
chondrocytes.  This cytokine increases metal lo-  
protease product ion [1, 2] as well as prostag landin  
E2 [3] and cytokine [4~] secretions. Al l  these 
syntheses need energy, and the impl icat ion of 
glucose as a nut r ient  is l ikely to be involved. There  
are no data concern ing the effect of IL-lfl on sugar  
uptake by OA chondrocytes.  A l though physiologi- 
cal regu lat ion  of glucose metabol ism in ar t i cu lar  
t issue is relat ively well-known, and is dependent  on 
the act ion of somatomedins,  part icu lar ly  insulin- 
l ike-growth factor  II [12]. 
IL-lfl is known to st imulate glucose uptake by 
dif ferent cell types in vitro such as human 
fibroblasts [13] or, more interestingly, synoviocytes 
[10, 14] in a time- and dose-dependent manner.  
In our  study, IL- l f l -mediated 2-DOG uptake by 
chondrocytes presents the same character ist ics.  
The occurrence  and rapidi ty of the effect on 
glucose uptake is dependent  on the cell  type. 
Chondrocytes appeared just  as sensitive to IL-lfl, 
when compared with OA human synovial cells [10], 
the intens i ty  of 2-DOG uptake was similar. 
However, the st imulat ing effect of the cytok ine was 
observed later (3-h incubat ion time vs I h for OA 
synoviocytes). The importance of the lag t ime in 
observing the effect of the cytokine excludes the 
modif icat ion of the recru i tment  of t ransporters .  
The possibi l i ty of a de novo carr ier  synthesis is 
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reinforced by the results of the experiment with 
CHX, which inhibited about 86% of the effect of 
IL-lfl on 2-DOG uptake. 
At pharmacological concentrations, cortisol 
possesses an inhibitory effect on IL-lfl-mediated 
2-DOG uptake by human cultured chondrocytes. 
A 6-h association time with cortisol appeared 
sufficient o inhibit the effect of lI~lfl on 2-DOG 
uptake. There are several possible mechanisms 
for the action of this hormone. Inhibition of the 
production ofprostaglandins [15] should be rejected 
because we demonstrated that indomethacin 
(10~ 6mol/1), which is known to inhibit prostaglandin 
E2 synthesis, was ineffective on 2-DOG uptake (data 
not shown). Cortisol could modify the intracellular 
movement of glucose carriers; this decreases their 
quantity in plasma membranes and increases the 
intracellular pool, as shown for dexamethasone i  
other cellular models and, particularly, human 
fibroblasts [16]. The effect of cortisol on IL-lfl-medi- 
ated glucose uptake could contribute to its 
usefulness in local administration by modulating 
the metabolism of articular chondrocytes. Exper- 
iments were carried out on first passage cells, which 
may already show evidence of some differentiation; 
however, the effect of cortisol is probably not 
modified because in a previous study [17] we 
demonstrated that chondrocyte glucocorticoid 
receptors were not altered during the culture. 
Finally, the stimulation of glucose uptake in 
articular chondrocytes is highly sensitive and 
responsive to the action of IL-lfl, suggesting that 
this cytokine might be a potent regulator of energy 
supply for these cells during inflammatory pro- 
cesses. The intensity of glucose uptake stimulation 
in chondrocytes makes them suitable for the study 
of the effects of IL-lfl inhibitors that are proposed 
for the treatment of OA. 
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